Why Private Equity Funds Are Key to India’s Healthcare Growth Story?

Image
  India’s healthcare sector is at a crossroads — caught between soaring demand and limited infrastructure. Urban hospitals are bursting at the seams, while rural regions still struggle with basic access to care. Amid these challenges, one powerful force is quietly but steadily reshaping the system: private equity funds .   In recent years, India has witnessed a surge in healthcare innovation — from telemedicine platforms and diagnostics startups to multi-specialty hospital chains. But innovation needs more than just good ideas; it needs capital, strategic direction, and long-term vision. That’s exactly where private equity investment in India has stepped in — and is now driving real, measurable impact.   Let’s explore why equity investment in India , especially through PE firms, has become the backbone of the country’s healthcare transformation.     The Rising Demand Meets Infrastructure Gaps   India is home to over 1.4 billion people, but the ratio of...

Nuances of Healthcare Business Models in India

While other businesses see ups and downs in investment due to external reasons, the healthcare sector remains intact at any point in time. So, like other industrial sectors such as FMCG, investment in healthcare also allows the investors to get a good return. 

equity funds india


During the lockdown period due to COVID-19, the healthcare sector performed well, although some losses were seen in this sector as well. Experts say that the healthcare sector provides a good opportunity for private equity funds in India

According to industry experts, the first step in investing in any business is to understand the business. The healthcare sector in India is not as complicated to understand as it seems. There are multiple business models within healthcare and the subtlety of each business is different. Hence, you have to pay attention to details before investing. 

Export Branded Generics Market

Most companies in India sell branded generics in India and other developing markets. These products are made by companies that own the brand and promote the product to the customer as well. This is a high return on equity business with very slow growth as the perception of allopathic medicines in India is still growing.

Exports Unbranded Generic Market

Many companies in India manufacture and sell unbranded generics to distributors in different developed countries such as the US, UK, etc. The products are not branded and hence there is no similarity between two manufacturers of the same product. This is a low RoE and highly capital-intensive business that sees bouts of volatility in pricing and volumes.

API Manufacturing

Some companies manufacture API and sell it to formulation manufacturers. API is a key raw material to manufacture formulations. This is a B2B business with varying levels of profitability depending on the product segments a company is functioning in.

Hospitals

Hospitals are generally either multi-specialty or super specialty. Super-specialty businesses can be very profitable if the brand is reputed and its reach is broad. Multi-specialty hospitals are less profitable compared to the former but get higher volumes and easier to scale up.

Comments

Popular posts from this blog

Private Equity’s Role in Tackling Global Healthcare Inequalities

The Effect of Private Equity Investment in Asia’s Health Care Sector

Private Equity Firms in India Drive Growth in Healthcare & MedTech